PhaseBio shares fall despite positive late-stage study results for lead drug candidate
November 15, 2021 at 13:24 PM EST
Shares were down 8% in early afternoon trading on Monday.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
